跳至主要内容
临床试验/EUCTR2006-003775-13-IT
EUCTR2006-003775-13-IT进行中(未招募)不适用

A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - ND

OSPEDALE ONCOLOGICO DI BARI0 个研究点目标入组 43 人开始时间: 2006年10月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Advanced loco-regional and/or metastatic recurrence of head and neck squamous cell carcinoma histologically or cytologically proven 2. No previous treatment with chemotherapy 3. Age 18 and 75 years 4. Life expectancy 3 months 5. Normal cardiac function 6. No gastrointestinal disorders that might affect the gastrointestinal absorption of Capecitabine
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. History of prior malignancy in the last 10 years 2. Concurrent treatment with other experimental drugs or participation in another clinical trial with ant investigational drug within 30 days prior to study screening 3. ASAT SGOT and/or ALAT SGPT 1.5 x UNL associated with alkaline phosphatase 2.5 x UNL 4. Other serious illness or medical condition

研究者

发起方
OSPEDALE ONCOLOGICO DI BARI

相似试验